Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.44 is 19% above its 5-year average of 1.21, near the low end of its 5-year range (0.00–12.85).
As of the fiscal period ended Tuesday, June 30, 2026. 25.71% below its 12-month average of 1.94.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.44.
CURRENT RATIO
1.44
CURRENT RATIO AVG TTM
1.94
CURRENT RATIO AVG 3Y
1.70
CURRENT RATIO AVG 5Y
1.21
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-25.71%
CURRENT VS 3Y AVG
-14.97%
CURRENT VS 5Y AVG
+19.04%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-61.65%
vs the sector median at left
bioAffinity Technologies, Inc.
Market Cap
$2.54M
Current Ratio
1.44
TTM Avg
1.94
3Y Avg
1.70
5Y Avg
1.21
Market Cap
$2.66M
Current Ratio
4.05
TTM Avg
3.31
3Y Avg
3.12
5Y Avg
3.30
Market Cap
$2.38M
Current Ratio
0.11
TTM Avg
0.75
3Y Avg
3.92
5Y Avg
2.68
Market Cap
$2.37M
Current Ratio
2.64
TTM Avg
2.37
3Y Avg
1.52
5Y Avg
1.27
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | $2.54M | 1.44 | 1.94 | 1.70 | 1.21 |
| Nuwellis, Inc. (NUWE)vs › | $2.56M | 1.97 | 2.58 | 3.16 | 4.38 |
| Jaguar Health, Inc. (JAGX)vs › | $2.44M | 0.69 | 1.06 | 1.22 | 1.34 |
| Universe Pharmaceuticals Inc. (UPC)vs › | $2.66M | 4.05 | 3.31 | 3.12 | 3.30 |
| iSpecimen Inc. (ISPC)vs › | $2.69M | 0.82 | 0.87 | 1.93 | 3.50 |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.38M | 0.94 | 1.19 | 3.93 | 6.93 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.38M | 0.11 | 0.75 | 3.92 | 2.68 |
| Onconetix, Inc. (ONCO)vs › | $2.37M | 2.21 | 0.36 | 1.94 | 12.76 |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.37M | 2.64 | 2.37 | 1.52 | 1.27 |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | 12.91 | 22.35 | 19.50 | 14.70 |
Current Ratio
1.44
Quick Ratio
1.41
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.44 |
| 2026-03-31 | 1.36 |
| 2025-12-31 | 2.60 |
| 2025-09-30 | 3.65 |
| 2025-06-30 | 0.64 |
| 2025-03-31 | 0.55 |
| 2024-12-31 | 0.87 |
| 2024-09-30 | 1.02 |
| 2024-06-30 | 1.15 |
| 2024-03-31 | 2.22 |
| 2023-12-31 | 1.77 |
| 2023-09-30 | 3.07 |
| 2023-06-30 | 11.17 |
| 2023-03-31 | 12.85 |
| 2022-12-31 | 10.50 |
| 2022-09-30 | 9.60 |
| 2022-06-30 | 0.02 |
| 2022-03-31 | 0.08 |
| 2021-12-31 | 0.11 |
| 2021-09-30 | 0.03 |
| 2021-06-30 | 0.00 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.01 |
